Pełna treść
3/2026
vol. 113
Artykuł przeglądowy
The Cryptic Invader: Midfacial Destruction in Extranodal NK/T-Cell Lymphoma – Case report with Narrative Review
Department of Dermatology, Seth GSMC and KEM Hospital, Mumbai, India
Fellow in Diagnostic Dermatology, Seth GS Medical College and KEM Hospital, Mumbai, India
Department of Otorhinolaryngology, Seth GSMC and KEMH, Mumbai, India
Dermatol Rev/Przegl Dermatol 2026, 113, 143–150
Data publikacji online: 2026/09/09
Plik artykułu
- Mehta V., Balachandran C., Bhat S., Geetha V., Fernandes D.: Nasal NK/T-cell lymphoma presenting as a lethal midline granuloma. Indian J Dermatol Venereol Leprol 2008, 74, 145-147.
- Tanaka H., Mori E., Akutsu T., Saito S., Tei M., Otori N.: Characteristics of extranodal NK/T-cell lymphoma, nasal type, compared with nasal diffuse large B-cell lymphoma. Clin Med Insights Oncol 2023, 17, 11795549231156692.
- Jaffe E.S.: Classification of natural killer (NK) cell and NK-like T-cell malignancies. Blood 1996, 87, 1207-1210.
- Patel V., Mahajan S., Kharkar V., Khopkar U. : Nasal extranodal NK/T-cell lymphoma presenting as a perforating palatal ulcer: a diagnostic challenge. Indian J Dermatol Venereol Leprol 2006, 72, 218-221.
- Alaggio R., Amador C., Anagnostopoulos I., Attygalle A.D., Araujo I.B.O., Berti E., et al.: The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 2022, 36, 1720-1748.
- Costa R.O., Pereira J., Lage L.A.P.C., Baiocchi O.C.G.: Extranodal NK-/T-cell lymphoma, nasal type: what advances have been made in the last decade? Front Oncol 2023, 13, 1175545.
- Thida A.M., Gohari P.: Extranodal NK-cell lymphoma. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.
- Tsai T.F., Su I.J., Lu Y.C., Cheng A.L., Yeh H.P., Hsieh H.C., et al.: Cutaneous angiocentric T-cell lymphoma associated with Epstein-Barr virus. J Am Acad Dermatol 1992, 26, 31-38.
- Kato N., Yasukawa K., Onozuka T., Kikuta H.: Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement. J Am Acad Dermatol 1999, 40, 850-856.
- Zhong B.N., Zhang X.H., Li M.G., Cao H.G., Li N., Liu C.Y., et al.: Study of the pathology, immunophenotype, etiology and genetic marker of NK/T-cell lymphoma. Zhonghua Xue Ye Xue Za Zhi 2003, 24, 505-509.
- Greer J.P., Kinney M.C., Loughran T.P. Jr.: T-cell and NK-cell lymphoproliferative disorders. Hematology Am Soc Hematol Educ Program 2001, 2001, 259-281.
- Stadlmann S., Fend F., Moser P., Obrist P., Greil R., Dirnhofer S.: Epstein-Barr virus-associated extranodal NK/T-cell lymphoma, nasal type of the hypopharynx, in a renal allograft recipient: case report and review of the literature. Hum Pathol 2001, 32, 1264-1268.
- Gourin C.G., Johnson J.T., Selvaggi K.: Nasal T-cell lymphoma: case report and review of diagnostic features. Ear Nose Throat J 2001, 80, 458-460.
- Arora N., Mehta A., Ravichandran S., Arun I., Achari R.B., Chakrapani A., et al.: NK/T-cell lymphoma: a tertiary centre experience. Indian J Hematol Blood Transfus 2017, 33, 69-73.
- Kim S.J., Lim J.Q., Yoon S.E., Yang D.H., Lee J.H., Oh S.Y., et al.: Efficacy of combined CD38 and programmed cell death protein-1 inhibition with isatuximab and cemiplimab for relapsed/refractory NK/T-cell lymphoma. Blood 2025, 146, 155-166.
Copyright: © 2026 Polish Dermatological Association. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
